Antimicrobial prescribing in European nursing homes.

OBJECTIVES The aim of this study was to investigate antimicrobial prescribing in nursing homes in countries across Europe. METHODS Point prevalence studies were completed in April and November 2009 in 85 nursing homes in 15 European countries and two UK administrations. RESULTS A total of 10,388 and 9430 residents participated in April and November 2009, respectively. The mean prevalence of antimicrobial prescribing in the nursing homes was 6.5% in April and 5.0% in November. The most commonly prescribed antimicrobials were methenamine (17.5%), trimethoprim (11.4%) and co-amoxiclav (11.1%) in April and co-amoxiclav (12.2%), nitrofurantoin (12.2%) and methenamine (11.5%) in November. There was large variation in the overall mean antimicrobial prescribing in the selected nursing homes from each of the contributing countries, ranging from 1.4% in Germany and Latvia to 19.4% in Northern Ireland in April and 1.2% in Latvia to 13.4% in Finland in November. Furthermore, differences in prescribing were apparent within countries with the largest variation evident in nursing homes in Northern Ireland (21.5%) in April and Finland in November (30.1%). CONCLUSIONS This is the first study to investigate antimicrobial prescribing in nursing homes in a large number of European countries. The findings suggest that there is considerable variation in antimicrobial prescribing in nursing homes across and within European countries. Nursing homes provide a significant service to the European community and must be supported in order to optimize antimicrobial use and limit the development of antimicrobial resistance.

[1]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[2]  Herman Goossens,et al.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. , 2011, The Journal of antimicrobial chemotherapy.

[3]  D. Dosa,et al.  Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes. , 2011, Archives of internal medicine.

[4]  H. Goossens,et al.  Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. , 2011, The Journal of antimicrobial chemotherapy.

[5]  H. Blix,et al.  How are antibacterials used in nursing homes? Results from a point‐prevalence prescription study in 44 Norwegian nursing homes , 2010, Pharmacoepidemiology and drug safety.

[6]  B. Murray,et al.  Antibiotic-resistant bugs in the 21st century--a clinical super-challenge. , 2009, The New England journal of medicine.

[7]  C. Suetens,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. , 2009, The Journal of antimicrobial chemotherapy.

[8]  J. Vaupel,et al.  Ageing populations: the challenges ahead , 2009, The Lancet.

[9]  N. Woodford,et al.  Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. , 2009, The Journal of antimicrobial chemotherapy.

[10]  C. Cardwell,et al.  Prevalence of Methicillin‐Resistant Staphylococcus aureus Colonization in Residents and Staff in Nursing Homes in Northern Ireland , 2009, Journal of the American Geriatrics Society.

[11]  H. Goossens,et al.  Antimicrobial Drug Use and Resistance in Europe , 2008, Emerging infectious diseases.

[12]  J. Jernigan,et al.  Factors Associated with Antimicrobial Use in Nursing Homes: A Multilevel Model , 2008, Journal of the American Geriatrics Society.

[13]  C. Lundborg,et al.  Infections and antibiotic prescribing in Swedish nursing homes: A cross-sectional study , 2008, Scandinavian journal of infectious diseases.

[14]  A. Holmes,et al.  The missing care bundle: antibiotic prescribing in hospitals. , 2007, International journal of antimicrobial agents.

[15]  T. Dellit.  Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[16]  N. Crogan,et al.  Clostridium difficile: an emerging epidemic in nursing homes. , 2007, Geriatric nursing.

[17]  H. Goossens,et al.  Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations , 2007, Pharmacoepidemiology and drug safety.

[18]  Hege Salvesen Blix,et al.  Large variation in antibacterial use among Norwegian nursing homes , 2007, Scandinavian journal of infectious diseases.

[19]  H. Goossens,et al.  Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). , 2006, The Journal of antimicrobial chemotherapy.

[20]  S. Straus,et al.  Interventions to improve antibiotic prescribing practices in ambulatory care. , 2005, The Cochrane database of systematic reviews.

[21]  C. Hughes,et al.  Managing Urinary Tract Infections in Nursing Homes: A Qualitative Assessment , 2005, Pharmacy World and Science.

[22]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[23]  D. Chutka,et al.  Antibiotic prescribing and outcomes following treatment of symptomatic urinary tract infections in older women. , 2004, Journal of the American Medical Directors Association.

[24]  R. Priore,et al.  Antibiotic Use, Hospital Admissions, and Mortality Before and After Implementing Guidelines for Nursing Home–Acquired Pneumonia , 2001, Journal of the American Geriatrics Society.

[25]  P A Gross,et al.  Implementing Practice Guidelines for Appropriate Antimicrobial Usage: A Systematic Review , 2001, Medical care.

[26]  S. Walter,et al.  Antibiotic use in ontario facilities that provide chronic care , 2001, Journal of General Internal Medicine.

[27]  S. Stone,et al.  Controlling infection in British nursing homes , 2001, BMJ : British Medical Journal.

[28]  N. Nugent,et al.  The European Commission , 2000 .

[29]  T. Yoshikawa,et al.  Epidemiology and unique aspects of aging and infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Philip Smith,et al.  Infection Prevention and Control in the Long-Term-Care Facility , 1997, Infection Control & Hospital Epidemiology.

[31]  Yves Jorens,et al.  Long term care in the European union , 2008 .

[32]  E. Kuijper,et al.  Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  S. Walter,et al.  Risk factors for resistance to antimicrobial agents among nursing home residents. , 2003, American journal of epidemiology.

[34]  J. Craig,et al.  Methenamine hippurate for preventing urinary tract infections. , 2002, The Cochrane database of systematic reviews.

[35]  J. Phair,et al.  Ageing and infection. , 1988, Ciba Foundation symposium.